Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucuronosyltransferase”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT00181662
What this trial is testing

Pharmacokinetics of Curcumin in Healthy Volunteers

Who this might be right for
Healthy
Massachusetts General Hospital 6
Not applicableEnded earlyNCT00131612
What this trial is testing

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

Who this might be right for
Breast Cancer
AHS Cancer Control Alberta 120
Early research (Phase 1)Study completedNCT01148004
What this trial is testing

The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

Who this might be right for
HIVFenofibrateProtease Inhibitors+2 more
National Institutes of Health Clinical Center (CC) 25
Large-scale testing (Phase 3)Study completedNCT05036421
What this trial is testing

Effect of Glucuronosyltransferase (UGT) Genetic Variation on Pharmacokinetics of Empagliflozin

Who this might be right for
PharmacogenomicPharmacokinetics
Ain Shams University 18
Early research (Phase 1)Study completedNCT00128947
What this trial is testing

Pharmacokinetics of Mycophenolate Mofetil in Healthy Volunteers

Who this might be right for
Healthy
National Institutes of Health Clinical Center (CC) 130
Testing effectiveness (Phase 2)WithdrawnNCT02977689
What this trial is testing

Trial of IDH305 in IDH1 Mutant Grade II or III Glioma

Who this might be right for
Glioma
NYU Langone Health